Therefore, inhibiting these CD24-related upstream molecules of regulatory signaling pathways can effectively prevent tumor invasion and immune escape, regulate tumor microenvironment, and thereby exert a positive effect on regressing tumor progression. This evidence concerns the gene CD24 and neoplasm.